Related Experiment Video

Updated: Apr 17, 2026

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery
08:43

Isolation of Endothelial Progenitor Cells from Healthy Volunteers and Their Migratory Potential Influenced by Serum Samples After Cardiac Surgery

Published on: February 14, 2017

11.6K

Endothelial Progenitor Cells and In-stent Restenosis

Bu-Yun Xu, Mei-Xiang Xiang1, Jian-an Wang

  • 1Cardiovascular Key Lab of Zhejiang Province, Department of Cardiology, the Second Affiliated Hospital, School of Medicine, 88 # Jiefang Road, Hangzhou, Zhejiang Province, P.R. China. xiangmxhz@163.com.

Current Stem Cell Research & Therapy
|February 6, 2015
PubMed

Insights

Coronary artery disease (CAD) treatment via percutaneous coronary intervention (PCI) can cause endothelial injury. Endothelial progenitor cells (EPCs) show promise for accelerating healing and preventing in-stent restenosis after PCI.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Cell Biology

Background:

  • Coronary artery disease (CAD) is a leading cause of death globally.
  • Percutaneous coronary intervention (PCI) is a common treatment for CAD.
  • PCI can lead to endothelial injury, inflammation, and in-stent restenosis, necessitating improved therapeutic strategies.

Purpose of the Study:

  • To review endothelial progenitor cells (EPCs).
  • To highlight the therapeutic potential of EPCs in accelerating re-endothelialization.
  • To explore EPCs' role in mitigating in-stent restenosis and endothelial injury post-PCI.

Main Methods:

  • Literature review of endothelial progenitor cells.
  • Analysis of EPC differentiation into endothelial cells.
  • Evaluation of cell therapy approaches using EPCs.

Main Results:

  • Endothelial progenitor cells (EPCs) possess the capacity to differentiate into mature endothelial cells.
  • EPCs represent a potential cell-based therapy for enhancing re-endothelialization.
  • EPCs may offer a novel therapeutic avenue for managing complications following PCI.

Conclusions:

  • Accelerating re-endothelialization after PCI is crucial for improving patient outcomes.
  • Endothelial progenitor cells (EPCs) hold significant therapeutic promise for cardiovascular applications.
  • Further research into EPC-based therapies could lead to advanced treatments for CAD complications.

More Related Videos

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood07:26

Isolation of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Published on: September 14, 2017

12.2K
Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia07:25

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia

Published on: September 22, 2020

3.9K

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.8K
Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.2K
Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.7K